Delivery Order SPE2DB20D7066-SPE2DB24FC2LR
Award Date
7/26/24
Potential Completion Date
8/16/24
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of KEDRAB 300 Unit/2 ML Vial 2ML, a pharmaceutical product. The contract has a firm fixed price of $3,242.70 and a period of performance through August 19, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999, which provides a comprehensive range of medical commodities to support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,891.24 fixed-price contract is for the supply of KEDRAB 300 UNIT/2 ML VIAL 2ML medical products. The contract has an ultimate completion date of October 9, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,626.70, is for the supply of KEDRAB, a 1,500 unit/10 mL vial of immunoglobulin. The contract is a firm fixed-price delivery order with a completion date of February 25, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The order is for the medical product KEDRAB, a 300 unit/2 ml vial. The contract has a ceiling value of $2,457.60 and a completion date of December 18, 2023. It is a firm fixed price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is valued at $1,624.37 and involves the delivery of 1,500 units of the KEDRAB 10 ML vial, a specialty medical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999, which provides a wide...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of KEDRAB 300 UNIT/2 ML VIAL 2ML. The contract has a ceiling value of $3,891.24 and is a firm fixed-price delivery order, with a period of performance through September 9, 2024. The contract is not set aside for any specific business type. This award is likely part of a larger Indefinite Delivery Contract (IDC) held by...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of KEDRAB, a 1,500 unit/10 ML vial of the drug, with a ceiling value of $24,365.55 and an ultimate completion date of August 26, 2024. The contract is a firm-fixed-price, delivery order type with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,891.24 firm fixed-price delivery order is for the supply of 4,565,188,727 units of the KEDRAB 300 IU/2 ML vial product. The contract has an ultimate completion date of August 8, 2024 and was awarded on July 18, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The contract is for the supply of KEDRAB, a 1,500 unit/10 ML vial of the drug, with a ceiling value of $12,994.96. The contract has a firm fixed price pricing type and an ultimate completion date of August 2, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $3,248.74 contract is for the delivery of 1,500 units of the pharmaceutical product KEDRAB (10 ML vial). The delivery order falls under a larger indefinite-delivery/indefinite-quantity (IDIQ) contract valued at up to $999,999,999 through December 2025, which provides a wide range of medical commodities to support military treatment...